Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
PaperCitations, authors & open-access status
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,133 citations, 2016 year and closed oa status.
1,133
Citations
2016
Year
closed
OA Status